MCK

MCKESSON CORP Overview: MCKESSON CORP (MCK) is a large-cap growth stock in the Major Drugs industry, receiving a 100% rating from Validea's Multi-Factor Investor model based on strong fundamentals and valuation.

Investment Strategy: The Multi-Factor Investor model, developed by Pim van Vliet, focuses on low volatility stocks with strong momentum and high net payout yields, indicating significant interest in MCK.

Pim van Vliet's Approach: Pim van Vliet, head of Conservative Equities at Robeco Asset Management, emphasizes that low volatility stocks can outperform high volatility ones with less risk, as detailed in his book "High Returns From Low Risk."

Validea's Research Service: Validea provides investment research based on strategies from renowned investors, offering stock analysis and model portfolios aimed at long-term market outperformance.

Warren Pies' Predictions: Strategist Warren Pies has accurately forecasted trends in stocks, bonds, and oil, with a notable prediction of the S&P 500 reaching 6,800 by the end of 2025.

Investor Sentiment: Pies believes that the average investor is overly concerned about the market being overvalued, suggesting a need for a shift in perspective.

52-Week Range of USMV: The USMV ETF has a 52-week low of $83.99 and a high of $95.59, with the last trade recorded at $94.31.

Understanding ETFs: Exchange-traded funds (ETFs) function like stocks, where investors buy and sell "units" that can be created or destroyed based on demand.

Monitoring ETF Flows: Weekly monitoring of shares outstanding helps identify ETFs with significant inflows (new units created) or outflows (units destroyed), impacting the underlying assets.

Disclaimer: The opinions expressed in the article are those of the author and do not necessarily represent the views of Nasdaq, Inc.